MMRV, COVID-19 Vaccine Guidance Changes – 5 Key Takeaways

Summary of Recent Vaccine Recommendations & Actions (September 2024)

This article details recent decisions made by the Advisory Committee on Immunization Practices (ACIP) and actions taken by various states regarding vaccine recommendations. Here’s a breakdown:

1. ACIP decisions (September 18-19,⁣ 2024):

* MMR & Varicella: ⁢ACIP voted to not cover the combined ⁣MMRV vaccine through the ⁣Vaccines for Children program, meaning it won’t be financially ‍accessible through that ‍program.The CDC currently recommends administering MMR and ‍varicella vaccines separately for the first dose, with the first dose between 12-15 months and the second⁤ between 4-6 years.
* Hepatitis B: A vote on delaying the first dose of the hepatitis B vaccine for infants with negative mothers was ⁤tabled due to confusion. However, the committee unanimously voted to recommend all pregnant women be tested for hepatitis B.
* ⁤ COVID-19:

⁣ ⁢ * ACIP recommends ⁢ shared decision-making between individuals 6 months and older‍ and thier healthcare providers regarding COVID-19 ⁢vaccination, emphasizing a risk-benefit analysis, notably for ‍those under‍ 65. This is a shift from‍ previous universal recommendations.
* A⁣ tie ⁣vote (6-6) on ‍requiring a prescription for COVID-19 vaccines was broken ⁢by the ACIP Chair, resulting in a decision⁤ against ‍requiring a prescription.
* ACIP unanimously recommended a⁣ more comprehensive informed consent process for COVID-19 vaccines, including discussion of risks and benefits.

2. State Actions:

* Several states are⁣ proactively ensuring vaccine access regardless of federal policy.
* West Coast Alliance⁢ (CA,⁤ OR,⁢ WA, HI): Released unified vaccine‍ recommendations for the 2025-26 season⁤ (flu, COVID-19, ‍RSV) ⁣based on guidelines ‍from medical associations like the AAP, ACOG, and AAFP. California ⁤passed a law allowing the state to base future vaccine guidance on autonomous medical ⁤associations, rather than ACIP.
* Northeast Public Health Collaborative⁣ (including New York): Taking similar action to coordinate vaccine guidance.

3.‍ Next Steps:

* ACIP’s recommendations are pending approval from the acting CDC director, Jim O’Neill, ⁤to ⁣become official ‍guidance.

In essence, the article highlights a move towards more individualized ⁢decision-making regarding vaccines, particularly‍ for COVID-19, and a growing trend of states taking‍ independent action on vaccine policy.